Food and Chemical Toxicology, 62 , 869875
Clinical Evidence Review (2025 Update) The clinical landscape of GHK-Cu has matured since the early 2000s, with several peer-reviewed human studies now confirming moderate but measurable benefits
The authors found that berberine: reduces blood glucose increases GLP-1, GLP-2, and peptide YY, which are substances that regulate metabolism and appetite may switch off genes that are responsible for cholesterol absorption The authors conclude that berberine may show promise for treating or preventing metabolic conditions, such as overweight or obesity
Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel
This maximum should never be exceeded, as doses above this threshold significantly increase the risk of serious liver damage, even in people with healthy livers